Consolidated Balance Sheets (Parenthetical) - USD ($) |
Mar. 31, 2025 |
Dec. 31, 2024 |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Investment, cost | $ 1,203,330,000 | [1] | $ 1,138,745,000 | [2] | ||||||||||||||||
Deferred financing costs, accumulated amortization | $ 6,622,000 | $ 6,449,000 | ||||||||||||||||||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | ||||||||||||||||||
Common stock, shares authorized (in shares) | 450,000,000 | 450,000,000 | ||||||||||||||||||
Common stock, shares issued (in shares) | 46,849,531 | 40,240,358 | ||||||||||||||||||
Common stock, shares outstanding (in shares) | 46,849,531 | 40,240,358 | ||||||||||||||||||
Series A Notes due 2026 | Unsecured Debt | ||||||||||||||||||||
Debt instrument, par value | $ 150,000,000 | $ 150,000,000 | ||||||||||||||||||
Control investments | ||||||||||||||||||||
Investment, cost | 54,788,000 | [1],[3] | 54,560,000 | [2],[4] | ||||||||||||||||
Affiliate investments | ||||||||||||||||||||
Investment, cost | 297,276,000 | [1],[5] | 284,211,000 | [2],[6] | ||||||||||||||||
Non‑Control/Non‑Affiliate investments | ||||||||||||||||||||
Investment, cost | $ 851,266,000 | [1],[7] | $ 799,974,000 | [2],[8] | ||||||||||||||||
|